Anti-nuclear antibodies in daily clinical practice: Prevalence in primary, secondary, and tertiary care

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Avery, Thomas Y ^a   Van De Cruys, Mart ^b   Austen, Jos ^a   Stals, Frans ^b   Damoiseaux, Jan G M C ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Zuyderland Medical Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIDFS70 ANTIBODY; ANTIEXTRACTABLE NUCLEAR ANTIGEN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; UNCLASSIFIED DRUG; ANTI-EXTRACTABLE NUCLEAR ANTIGEN ANTIBODIES;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIBODY TITER; ARTICLE; ASSAY; AUTOIMMUNE DISEASE; CHILD; CLINICAL PRACTICE; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMMUNOADSORPTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SCREENING; SECONDARY HEALTH CARE; SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE; TERTIARY HEALTH CARE; VERY ELDERLY; AUTOIMMUNE DISEASES; BLOOD; DIAGNOSTIC USE; EPIDEMIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; HEALTH SURVEY; MIDDLE AGED; PRIMARY HEALTH CARE; PROCEDURES; RHEUMATIC DISEASES; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PRIMARY HEALTH CARE; RHEUMATIC DISEASES; SECONDARY CARE; SEROEPIDEMIOLOGIC STUDIES; TERTIARY HEALTHCARE; YOUNG ADULT;

EID: 84897533936     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/401739     Document Type: Article

References (28)

1. Solomon D. H., Kavanaugh A. J., Schur P. H., Solomon D. H., Schur P., Kavanaugh A. F., Reveille J. D., Sherrer Y. R. S., Lahita R., The American College of Rheumatology ad hoc Committee on Immunologic Testing Guidelines, Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Care and Research 2002 47 4 434 444 2-s2.0-0037103187 (Pubitemid 34856134)
2. Damoiseaux J. G. M. C., Cohen Tervaert J. W., From ANA to ENA: how to proceed? Autoimmunity Reviews 2006 5 1 10 17 2-s2.0-28744449120 10.1016/j.autrev.2005.05.007 (Pubitemid 41759437)
3. Agmon-Levin N., Damoiseaux J. G. M. C., Kallenberg C., International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies (ANA). Annals of Rheumatic Diseases 2014 73 17 23
4. Sack U., Conrad K., Csernok E., Frank I., Hiepe F., Krieger T., Kromminga A., Von Landenberg P., Messer G., Witte T., Mierau R., German EASI (European Autoimmunity Standardization Initiative), Autoantibody detection using indirect immunofluorescence on HEp-2 cells. Annals of the New York Academy of Sciences 2009 1173 166 173 2-s2.0-69949171146 10.1111/j.1749-6632.2009.04735.x
5. Meroni P. L., Schur P. H., ANA screening: an old test with new recommendations. Annals of the Rheumatic Diseases 2010 69 8 1420 1422 2-s2.0-77955462255 10.1136/ard.2009.127100
6. Tan E. M., Cohen A. S., Fries J. F., The 1982 revised criteria for the classification of systemic lupus erythrematosus. Arthritis and Rheumatism 1982 25 11 1271 1277 2-s2.0-0020436689 (Pubitemid 13221242)
7. Hochberg M. C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and rheumatism 1997 40 9 1725 2-s2.0-0031229830
8. Alvarez F., Berg P. A., Bianchi F. B., Bianchi L., Burroughs A. K., Cancado E. L., Chapman R. W., Cooksley W. G. E., Czaja A. J., Desmet V. J., Donaldson P. T., Eddleston A. L. W. F., Fainboim L., Heathcote J., Homberg J.-C., Hoofnagle J. H., Kakumu S., Krawitt E. L., Mackay I. R., MacSween R. N. M., Maddrey W. C., Manns M. P., McFarlane I. G., Meyer Zum Büschenfelde K.-H., Mieli-Vergani G., Nakanuma Y., Nishioka M., Penner E., Porta G., Portmann B. C., Reed W. D., Rodes J., Schalm S. W., Scheuer P. J., Schrumpf E., Seki T., Toda G., Tsuji T., Tygstrup N., Vergani D., Zeniya M., International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. Journal of Hepatology 1999 31 5 929 938 2-s2.0-0032718310 10.1016/S0168-8278(99)80297-9 (Pubitemid 29514229)
9. Kavanaugh A. F., Solomon D. H., The American College of Rheumatology ad hoc Committee on Immunologic Testing Guidelines, Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Care and Research 2002 47 5 546 555 2-s2.0-0037109270 (Pubitemid 35291379)
10. Tan E. M., Feltkamp T. E. W., Smolen J. S., Butcher B., Dawkins R., Fritzler M. J., Gordon T., Hardin J. A., Kalden J. R., Lahita R. G., Maini R. N., McDougal J. S., Rothfield N. F., Smeenk R. J., Takasaki Y., Wiik A., Wilson M. R., Koziol J. A., Range of antinuclear antibodies in "healthy" individuals. Arthritis and Rheumatism 1997 40 9 1601 1611 2-s2.0-0030830193 10.1002/art.1780400909 (Pubitemid 27426153)
11. Op de Beéck K., Vermeersch P., Verschueren P., Westhovens R., Mariën G., Blockmans D., Bossuyt X., Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmunity Reviews 2011 10 12 801 808 2-s2.0-80053274380 10.1016/j.autrev.2011.06.005
12. Op de Beéck K., Vermeersch P., Verschueren P., Westhovens R., Mariën G., Blockmans D., Bossuyt X., Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmunity Reviews 2012 12 2 137 143 2-s2.0-84858731414 10.1016/j.autrev.2012. 02.013
13. Abeles A. M., Abeles M., The clinical utility of a positive antinuclear antibody test result. The American Journal of Medicine 2013 126 4 342 348
14. Peene I., van Ael W., Vandenbossche M., Vervaet T., Veys E., de Keyser F., Sensitivity of the HEp-2000 substrate for the detection of anti-SSA/Ro60 antibodies. Clinical Rheumatology 2000 19 4 291 295 2-s2.0-0033856074 (Pubitemid 30612561)
15. Bossuyt X., Meurs L., Mewis A., Mariën G., Blanckaert N., Screening for autoantibodies to SS-A/Ro by indirect immunofluorescence using HEp-2000 cells. Annals of Clinical Biochemistry 2000 37 2 216 219 2-s2.0-0033998194 (Pubitemid 30122248)
16. Villalta D., Bizzaro N., Corazza D., Tozzoli R., Tonutti E., Evaluation of a new automated enzyme fluoroimmunoassay using recombinant plasmid dsDNA for the detection of anti-dsDNA antibodies in SLE. Journal of Clinical Laboratory Analysis 2002 16 5 227 232 2-s2.0-0036389087 10.1002/jcla.10045
17. Infantino M., Bentow C., Seaman A., Benucci M., Atzeni F., Sarzi-Puttini P., Olivito B., Meacci F., Manfredi M., Mahler M., Highlights on novel technologies for the detection of antibodies to Ro60, Ro52, and SS-B. Clinical and Developmental Immunology 2013 2013 10 978202 10.1155/2013/978202
18. Narain S., Richards H. B., Satoh M., Sarmiento M., Davidson R., Shuster J., Sobel E., Hahn P., Reeves W. H., Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting. Archives of Internal Medicine 2004 164 22 2435 2441 2-s2.0-10344222129 10.1001/archinte.164.22.2435 (Pubitemid 39628070)
19. Marin G. G., Cardiel M. H., Cornejo H., Viveros M. E., Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. Journal of Clinical Rheumatology 2009 15 7 325 329 2-s2.0-70350135961 10.1097/RHU.0b013e3181bb971b
20. Satoh M., Chan E. K. L., Ho L. A., Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis and Rheumatism 2012 64 7 2319 2327
21. Mahler M., Fritzler M. J., The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases. Clinical and Developmental Immunology 2012 2012 6 494356 10.1155/2012/494356
22. Mariz H. A., Sato E. I., Barbosa S. H., Rodrigues S. H., Dellavance A., Andrade L. E. C., Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis and Rheumatism 2011 63 1 191 200 2-s2.0-78650787263 10.1002/art.30084
23. Ganapathy V., Casiano C. A., Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us? Arthritis and Rheumatism 2004 50 3 684 688 2-s2.0-1542373697 10.1002/art.20095 (Pubitemid 38326165)
24. Bizzaro N., Tonutti E., Villalta D., Recognizing the dense fine speckled/lens epithelium-derived growth factor/p75 pattern on HEP-2 cells: not an easy task! Comment on the article by Mariz et al. Arthritis and Rheumatism 2011 63 12 4036 4037 2-s2.0-82455163762 10.1002/art.30621
25. Mahler M., Hanly J. G., Fritzler M. J., Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmunity Reviews 2012 11 9 642 645 2-s2.0-83655202759 10.1016/j.autrev.2011.11.005
26. Bossuyt X., Fieuws S., Detection of antinuclear antibodies: added value of solid phase assay? Annals of the Rheumatic Diseases 2014 73 e11 10.1136/annrheumdis-2013-204793
27. Bentow C., Swart A., Wu J., Seaman A., Manfredi M., Infantino M., Benucci M., Lakos G., Mahler M., Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens. Clinica Chimica Acta 2013 424 141 147
28. Yazdani J., Schmajuk G., Robbins M., Choosing wisely: the American College of Rheumatology's top 5 list of things physicians and patients should question. Arthritis Care and Research 2013 65 3 329 339